Purpose: Renal disease is usually progressive. The length of each stage varies and depends on how kidney disease is treated. In the United States, approximately 14% of the population has chronic kidney disease (CKD) and more than 661,000 Americans have renal failure. In this module, a case study involving a patient with CKD and declining renal function is examined. Participants will be provided an in-depth analysis of the patients’ history, physical findings, and key laboratory values. Implementation of evidence-based and collaborative treatment practices by an interdisciplinary team will be reviewed.
Speaker Name and Title:
Russell K. Portenoy, MD
Executive Director, MJHS Institute for Innovation in Palliative Care
Chief Medical Officer, MJHS Hospice & Palliative Care
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students.
Disclosures:
Russell K. Portenoy, MD, Moderator, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support.
Learning Objectives:
1) Discuss the knowledge and skills necessary in the assessment and management of symptoms that commonly occur in patients with severe renal dysfunction
2) Recognize knowledge and skills necessary in having goals discussions concerning the start of dialysis in patients with chronic kidney disease
3) Describe the knowledge and skills necessary to the collaborative interdisciplinary practice of palliative care in populations with severe renal dysfunction
Training Initiative: Healthcare Transformation, Primary Care/Chronic Disease
Title: Palliative Care Series: Assessment and Management of Severe Renal Dysfunction
Training Mode: Online
Contact Hours: 1h
Type: Certificate
Comments